DTWD1 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting DTWD1 in the near-haploid human HAP1 cell line. This gene-disrupted pool provides a genetically engineered loss-of-function model for investigating the biological role of DTWD1, a predicted nucleic acid-binding protein containing a DTW domain. The polyclonal format offers a heterogeneous population of edited cells, enabling robust functional studies without the clonal artifacts associated with single-cell-derived lines.
HAP1 cells are derived from KBM-7, a near-haploid human cell line from a male chronic myeloid leukemia patient. With a fibroblast-like morphology, these cells retain a largely haploid karyotype (except for a disomy of chromosome 8), making them an ideal platform for gene-editing studies. Their haploid nature simplifies genetic analysis and ensures that CRISPR/Cas9-mediated disruptions lead to functional knockout without the complexity of diploid gene compensation. HAP1 cells are widely employed in functional genomics, drug target identification, and haploid genetic screens.
DTWD1 encodes a protein harboring a DTW domain, which shares homology with archaeal tRNA-modifying enzymes. This suggests a potential role in RNA modification, possibly catalyzing the enzymatic alteration of tRNA or other RNA species. DTWD1 may act as a nucleic acid-binding enzyme, but its precise substrates, interacting partners, and regulatory mechanisms remain uncharacterized. The absence of identified upstream regulators, downstream targets, or interacting proteins underscores the early-stage understanding of this gene’s biological context, making these knockout cells a valuable tool to probe unknown functional relationships.
The combination of DTWD1 disruption and the HAP1 near-haploid background generates a powerful system for dissecting gene function in RNA biology. Since HAP1 cells express key components of tRNA modification machinery, this knockout model allows researchers to assess the impact of DTWD1 loss on RNA processing pathways without confounding genetic redundancy. The haploid state ensures a direct genotype-phenotype correlation, facilitating the detection of subtle phenotypes arising from defective tRNA modification, making the cell pool particularly suited for high-content screening and high-throughput approaches aimed at mapping RNA modification networks.
These polyclonal knockout cells are ideal for functional characterization of DTWD1 through phenotypic profiling, including cell viability assays, proliferation studies, and morphological analyses. Transcriptomic and epitranscriptomic investigations via RNA sequencing can reveal alterations in RNA modification patterns upon DTWD1 loss. Standard validation techniques such as genotyping PCR, western blotting, and RT-qPCR confirm target gene disruption and expression changes. This tool supports diverse applications, from basic research into tRNA biology to drug discovery screens targeting RNA-modifying enzymes. For additional details, please contact Ascent Research.
